B-Vaxx/PD1-Vaxx(Imugene)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameB-Vaxx/PD1-Vaxx(Imugene)
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionReceptor tyrosine-protein kinase erbB-3 antagonistsImmunostimulantsProgrammed cell death protein 1 blockers +[5] 
TargetsReceptor protein-tyrosine kinase erbB-2Receptor tyrosine-protein kinase erbB-3Programmed cell death protein 1
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImugene Ltd
China Registration ClassN/A

Develop Information

Active CompaniesImugene Ltd
Inactive CompaniesN/A
Active IndicationsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A